13F-HR filed by Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Investors, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 34 holding rows worth $800,117,000.
- Accession
- 0000950123-23-005321
- Filer
- CIK 1703031
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 34 entries on the cover page, a total value of $800,117,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $800,117,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-18477. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBain Capital Life Sciences Partners, LP 028-18476
- included managerBain Capital Life Sciences Fund, L.P. 028-18478
- included managerBC SW, LP 028-20270
- included managerBain Capital Life Sciences Investors II, LLC 028-20816
- included managerBain Capital Life Sciences Fund II, L.P. 028-20814
- included managerBCLS II Investco (GP), LLC 028-22976
- included managerBCLS II Investco, LP 028-22978
- included managerBain Capital Life Sciences III General Partner, LLC 028-22975
- included managerBain Capital Life Sciences Fund III, L.P. 028-22979
- included managerBain Capital Life Sciences Opportunities III GP, LLC 028-22968
- included managerBain Capital Life Sciences Opportunities III, LP 028-22966
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 8,300,000 | $110,058,000 | thousands, detected and multiplied | |
| NUVALENT INC COM | 670703107 | Stock | 3,577,267 | $93,331,000 | thousands, detected and multiplied | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,081,307 | $79,313,000 | thousands, detected and multiplied | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,990,914 | $42,187,000 | thousands, detected and multiplied | |
| NATERA INC COM | 632307104 | Stock | 700,197 | $38,875,000 | thousands, detected and multiplied | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 3,915,000 | $38,406,000 | thousands, detected and multiplied | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 2,305,558 | $37,027,000 | thousands, detected and multiplied | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 8,663,673 | $35,608,000 | thousands, detected and multiplied | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 3,000,000 | $33,000,000 | thousands, detected and multiplied | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 3,400,000 | $27,506,000 | thousands, detected and multiplied | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 3,180,601 | $25,620,000 | thousands, detected and multiplied | |
| SAVARA INC | 805111101 | COM | 11,622,598 | $22,664,000 | thousands, detected and multiplied | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,500,000 | $21,800,000 | thousands, detected and multiplied | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 4,702,996 | $19,753,000 | thousands, detected and multiplied | |
| EQRX INC | 26886C107 | COM | 10,003,573 | $19,407,000 | thousands, detected and multiplied | |
| ANNEXON INC | 03589W102 | COM | 4,886,616 | $18,813,000 | thousands, detected and multiplied | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,822,883 | $16,187,000 | thousands, detected and multiplied | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 3,130,422 | $14,838,000 | thousands, detected and multiplied | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 1,408,901 | $14,371,000 | thousands, detected and multiplied | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 8,434,560 | $11,049,000 | thousands, detected and multiplied | |
| CARA THERAPEUTICS INC | 140755109 | COM | 2,204,449 | $10,824,000 | thousands, detected and multiplied | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 12,202,510 | $10,616,000 | thousands, detected and multiplied | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 1,431,058 | $9,874,000 | thousands, detected and multiplied | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 2,805,413 | $8,893,000 | thousands, detected and multiplied | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 2,485,638 | $8,327,000 | thousands, detected and multiplied | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,921,790 | $7,591,000 | thousands, detected and multiplied | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 2,124,694 | $5,673,000 | thousands, detected and multiplied | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 2,000,000 | $5,540,000 | thousands, detected and multiplied | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,642,210 | $5,157,000 | thousands, detected and multiplied | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 640,631 | $2,639,000 | thousands, detected and multiplied | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 1,937,207 | $2,325,000 | thousands, detected and multiplied | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 5,347,689 | $1,551,000 | thousands, detected and multiplied | |
| APTINYX INC | 03836N103 | COM | 8,891,758 | $1,110,000 | thousands, detected and multiplied | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 100,000 | $184,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-005321 | this filing | 2023-05-15 | acceptance time not in the bulk data set |